
What We Do
Creating a healthier world through affordable biologics
What We Do
We develop and manufacture biologic medicines across multiple therapeutic areas, including autoimmune diseases, oncology, metabolic disorders, infertility, and infectious disease.
Our portfolio includes recombinant proteins, monoclonal antibodies, and biosimilars, each requiring rigorous characterization, tightly controlled production systems, and consistent clinical performance.
We don't see biologics as "products." We see them as living science, and we treat them with the precision and respect that living science demands.
Core Strategic Pillars

Industrial Maturity

A Catalyst for Innovation

Uncompromising Quality

Global Integration
Our Business
Discover what makes CinnaGen a leader in the biopharmaceutical industry

